Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1.

The penetration of aztreonam into cerebrospinal fluid was 7 to 15% and 9 to 25%, respectively, in experimental Haemophilus influenzae type b and Escherichia coli K1 meningitis. Aztreonam was effective in reducing the number of organisms in cerebrospinal fluid after single-dose and continuous infusio...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	McCracken, G H, Sakata, Y, Olsen, K D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1985
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180117/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3890733/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.655
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!